Effect of p27KIP1 on cell cycle and apoptosis in gastric cancer cells

World Journal of Gastroenterology

Volumn 11, Issue 45, 2005, Pages 7072-7077

  Zhen, Jian Yong ^a   Wang, Wei Zhong ^a   Li, Kai Zong ^a   Guan, Wen Xian ^a   Yan, Wei ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Gastric neoplasm; P27KIP1

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LIPOFECTAMINE; MESSENGER RNA; ZINC;

AGAR MEDIUM; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CARCINOGENICITY; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL GROWTH; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HISTOGRAM; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOSIS INHIBITION; NICK END LABELING; NONVIRAL GENE DELIVERY SYSTEM; NUDE MOUSE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; STOMACH CARCINOMA; WESTERN BLOTTING;

EID: 31544434519     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i45.7072     Document Type: Article

References (27)

1. Krug U, Ganser A, Koeffler HP. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 2002; 21: 3475-3495
2. Nho RS, Sheaff RJ. p27kip1 contributions to cancer. Prog Cell Cycle Res 2003; 5: 249-259
3. Hengst L, Dulic V, Slingerland J, Lees E, Reed S. A cell cycle regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci USA 1994; 91: 5291-5295
4. Blain SW, Scher HI, Cordon-Cardo C, Koff A.. p27 as a target for cancer therapeutics. Cancer Cell 2003; 3: 111-115
5. Alkarain A, Slingerlan J. Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Res 2004; 6: 13-21
6. Chetty R. p27 Protein and cancers of the gastrointestinal tract and liver: an overview. J Clin Gastroenterol 2003; 37: 23-27
7. Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 1996; 382: 325-331
8. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R, Tsukiyama T, Ishida N, Kitagawa M, Nakayama K, Hatakeyama S. Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J 2000; 19: 2069-2081
9. Lloyd RV, Erickson LA, JIN L, Kulig E, Qian X, Cheville JC, Scheithauer BW. p27KIP1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999, 154: 313-323
10. Davison EA, Lee CS, Naylor MJ, Oakes SR, Sutherland RL, Hennighausen L, Ormandy CJ, Musgrove EA. The cyclin-dependent kinase inhibitor p27 (Kip1) regulates both DNA synthesis and apoptosis in mammary epithelium but is not required for its functional development during pregnancy. Mol Endocrinol 2003; 17: 2436-2447
11. Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH, Seth P. Promoting apoptosis: a novel activited with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997; 57: 5441-5445
12. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156
13. Bani-Hani KE, Yaghan RJ, Heis HA, Shatnawi NJ, Matalka II, Bani-Hani AM, Gharaibeh KA. Gastric malignancies in Northern Jordan with special emphasis on descriptive epidemiology. World J Gastroenterol 2004; 10: 2174-2178
14. Wong JE, Ito Y, Correa P, Peeters KC, van de Velde CJ, Sasako M, Macdonald J. Therapeutic strategies in gastric cancer. J Clin Oncol 2003; 21: S267-269
15. Oluwasola AO, Ogunbiyi JO. Gastric cancer: aetiological, clinicopathological and management patterns in Nigeria. Niger J Med 2003; 12: 177-186
16. Ohtani M, Isozaki H, Fujii K, Nomura E, Niki M, Mabuchi H, Nishiguchi K, Toyoda M, Ishibashi T, Tanigawa N. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma. Cancer 1999; 85: 1711-1718
17. Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Am J Gastroenterol 1999; 94: 1658-1663
18. Nitti D, Belluco C, Mammano E, Marchet A, Ambrosi A, Mencarelli R, Segato P, Lise M. Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J Surg Oncol 2002; 81: 167-175; discussion 175-176
19. Philipp-Staheli J, Kim KH., Payne SR., Gurley KE, Liggitt D, Longto G, Kemp CJ. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 2002; 1: 355-368
20. Fernandez PL, Arce Y, Farre X, Martinez A, Nadal A, Rey MJ, Peiro N, Campo E, Cardesa A. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression. J Pathol 1999; 187: 563-566
21. Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998; 58: 542-548
22. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000; 183: 10-17
23. Tsihlias J, Kapusta L, Slingerland J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med 1999; 50: 401-423
24. Katner AL, Gootam P, Hoang QB, Gnarra JR, Rayford W. A recombinant adenovirus expressing p7(Kip1) induces cell cycle arrest and apoptosis in human 786-0 renal carcinoma cells. J Urol 2002; 168: 766-773
25. Katner AL, Hoang QB, Gootam P, Jaruga E, Ma Q, Gnarra J, Rayford W. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1). Prostate 2002; 53: 77-87 [PMID: 12210483]
26. Cipriano SC, Chen L, Burns KH, Koff A, Matzuk MM. Inhibin and p27 interact to regulate gonadal tumorigenesis. Mol Endocrinol 2001; 15: 985-996
27. Sotillo R, Dubus P, Martin J, de la Cueva E, Ortega S, Malumbres M, Barbacid M. Wide spectrum of tumors in knockin mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J 2001; 20: 6637-6647